Oxybutynin Tstransdermal Patch 3.9 mg/24 hours Suppliers & Bulk Manufacturers
Available Forms: transdermal patch
Available Strengths: 3.9 mg/24 hours
Reference Brands: Oxytrol, Oxytrol for Women(US & EU)
Category: Urology
Oxybutynin transdermal patches deliver medication directly through the skin, blocking muscarinic receptors to reduce bladder muscle contractions. Benefits include steady drug levels, fewer side effects, improved patient compliance, reduced urgency and frequency, and better overall bladder control, supporting long-term management of overactive bladder with enhanced comfort.
Product Description:
Oxybutynin transdermal patches, marketed as Oxytrol, are approved in the US by the FDA and in the EU via EMA for managing overactive bladder. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical and quality information, while the EMA ensures compliance with regional safety and manufacturing standards.
Oxybutynin Tstransdermal Patch — third party manufacturing & bulk supply
Oxybutynin Tstransdermal Patch 3.9 mg/24 hours is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Oxybutynin Tstransdermal Patch listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Oxybutynin Tstransdermal Patch →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Oxybutynin is used for the treatment of overactive bladder with symptoms such as urinary urgency, increased frequency of urination, and urge incontinence. It helps control involuntary bladder contractions and improves bladder capacity.
Oxybutynin products are made from oxybutynin, commonly formulated as oxybutynin hydrochloride. It is an anticholinergic (antimuscarinic) agent that works by relaxing the smooth muscle of the bladder and reducing urinary spasms.
Common trade names include Ditropan, Ditropan XL, and Oxytrol.
Ditropan was originally developed and marketed by Janssen Pharmaceuticals. Oxytrol has been marketed by different companies depending on the region. Generic oxybutynin products are manufactured by multiple pharmaceutical companies worldwide.
The generic name is oxybutynin hydrochloride.
Brand names include Ditropan, Ditropan XL, and Oxytrol.
Oxybutynin products are manufactured in GMP-certified pharmaceutical facilities in the United States, Europe, India, and other regulated markets depending on the marketing authorization holder and supplier. Specific manufacturing locations vary by brand and batch.
Related Products
Phenazopyridine Hydrochloride
Strength:
95 mg, 100 mg, 200 mg
Form: Tablets
Reference Brands: Pyridium (USA), Pyridox (EU), Uristat (India)
View DetailsDutasteride + Tamsulosin
Strength:
0.5 mg + 0.4 mg
Form: Capsules
Reference Brands: Jalyn (USA), Dutamul (India), Duodart (EU)
View DetailsTrospium Chloride
Strength:
20 mg, 60 mg
Form: Tablets
Reference Brands: Sanctura (USA), Spasmex (EU)
View DetailsSolifenacin Succinate
Strength:
5 mg ,10 mg
Form: Tablets
Reference Brands: Vesicare (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers